Figure 1B shows that single dose of DOX, DUL 0.6 mg/kg and DUL 0.2 mg/kg did not significantly affect relative kidney weight compared to NC group (p=0.9762, 0.2413, and 0.6119 respectively)
It is thus apparent that the currently used strategies to predict drug-induced injury warrant strong improvements
Low Platelet Count and Pregnancy There can be several reasons why pregnant women develop a low platelet count
Clinical stage: As of now, Cagrilintide is still in Phase II/III trials, with early results showing significant reductions in body weight compared to placebo
Your physicians evaluate your health history, body mass index, lifestyle, and weight loss goals
Originally developed by Russian scientist Professor Vladimir Khavinson at the St